BioSpace News Archive

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will present at the Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 9:00 a.m. ET. The live audio cast will be available at https://www.webcaster4.com/Webcast/Page/2513/37778 and it will be accessible for replay for 90 days following the conference. The company’s management team, incl

Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today announced financial results for its fourth quarter and year ended June 30, 2020.

Southern Lithoplate, Inc., (SLP), a national manufacturer and marketer with facilities in the North Carolina Research Triangle, has expanded its capacity for producing and shipping its commercially packaged, “Spray and Walk Away” sanitizer product for large scale distribution across the U.S. The SLP sanitizer product,

Aytu BioScience, Inc. (NASDAQ:AYTU) (the “Company”), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that it will reschedule its fourth quarter and FY 2020 conference call, previously scheduled for Thursday, September 24 at 4:30pm ET.

Gilead Sciences, Inc. announced the pricing of senior unsecured notes in an aggregate principal amount of $7.25 billion, in an underwritten, registered public offering, consisting of seven tranches

Zogenix, Inc. announced the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, today announced new hire grants totaling an aggregate of 23,500 inducement restricted stock awards (“RSAs”) to five employees. The RSAs vest over four years, with 25% of the underlying shares vesting on each o

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to announce the addition of Ms. Wendy S. Johnson as an additional independent member to its Board of Directors, effective October 1, 2020. Ms. Johnson will also serve on the Audit Committee. “We are excited to have added Ms. Wendy Johnson to our Board of Directors,” said Ron Rocca, Exagen’s President an

Centene Corporation announced that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 3.00% senior notes due 2030.

Francis S. Collins, M.D., Ph.D., the 16th Director of the National Institutes of Health (NIH) will deliver brief remarks and engage in a virtual Q&A on the latest COVID-19 therapeutic and vaccine developments and how the agency is helping to promote research and engagement in communities hardest hit by COVID-19 at a National Press Club Virtual Newsmaker presentation on Monday, September 28 at 3:30 p.m.